Listly by Hollie Williams
The Sandler-Kenner Foundation’s primary focus is to improve survivability of pancreatic cancer patients by developing early identification tools that are highly sensitive, cost effective and easily implemented by medical practitioners.
Pancreatic cancer is the fourth leading cause of cancer deaths. Find out how to donate and help fund pancreatic cancer research, information and support. Call: 214-379-2779 for more information.
Read about pancreatic cancer symptoms, disease diagnosis, prognosis, risk factors, side effects of treatment for cancer of the pancreas. Donate now and help us support people diagnosed with pancreatic cancer and their families.
Pancreatic cancer remains one of the most frightening diagnosis and treatment depends on the stage. Making a donation to The Sandler-Kenner Foundation helps our research on finding a cure for pancreatic cancer.
The Sandler-Kenner Foundation’s medical and scientific funding decisions are guided in part by its Foundation Leadership and Scientific Advisory Board members.
Donate to the Sandler-Kenner Foundation and join the fight against pancreatic cancer. Your charity and donation supports our mission to save lives. Call: 214-379-2779 for more information.
Our board members have tremendous passion for our cause. Your donation supports comprehensive approach to fighting pancreatic cancer.
Giving hope to those suffering from pancreatic cancer. Join the fight against pancreatic cancer by making a donation online to Sandler-Kenner Foundation.
If you want to make a donation of shares through a direct transfer to the Sandler-Kenner Foundation, your agent can help you. Giving a donation of publicly traded shares, which increased its value, and has been owned for more than a year can provide greater tax benefits than giving cash.
Pancreatic cancer affects an estimated 49,000 American each year. New research is finding that hope may lie in the KRAS gene. More than 95 percent of pancreatic cancers are known to present with this gene mutation.
As related deaths rise pancreatic cancer in the United States, the disease is on track to overtake breast cancer as the third leading cause of death in the United States. Researchers also believe that pancreatic cancer will soon become the second leading cause of cancer-related deaths in the United States.
Know about pancreatic cancer signs and symptoms. At Sandler-Kenner Foundation our goal is to educate the public about the signs and symptoms of pancreatic cancer so that medical care can be sought earlier in its course.
Learn about the causes of Pancreatic Cancer and its risk factors. Help for early detection and treatment.
Read here for a list of common medications used to treat or reduce the symptoms of Pancreatic Cancer.
Recent research has found that incretin-based drugs do not elevate pancreatic cancer risks in those who use them on a regular basis.
Researchers in Europe have found that pancreatic cancer is technically four separate diseases. The types are squamous, pancreatic progenitor, immunogenic and ADEX, researchers say.
Pancreatic cancer survival rates remain grim, but work is well under way to change that. People can take an active role in helping by knowing their risks, raising awareness and assisting in fundraising that supports continued research.
Helping provide pancreatic cancer support through awareness, fundraising and helping patients and families directly can all make a difference.
Researchers are working with intensity to develop better treatments for this form of cancer and more effective screening tools. In the meantime, it is recommended those at risk take steps to lower their likelihood of developing this disease.
When symptoms appear in people at higher risk for this disease, doctors may recommend screening. Understanding personal risks and symptoms can help lead to a more rapid diagnosis should the disease present.
Enter a possible new way to find this disease in its earlier, more treatable stages. Researchers at Barts Cancer Institute at Queen Mary University of London say they have developed a possible urine test that may lead to earlier detection of the disease.